Maximum tumor diameter is a simple and valuable index associated with the local extent of disease in clinically localized prostate cancer

International Journal of Urology

Volumn 13, Issue 7, 2006, Pages 951-955

  Mizuno, Ryuichi ^a   Nakashima, Jun ^a   Mukai, Makio ^b   Ookita, Hajime ^b   Nakagawa, Ken ^a   Oya, Mototsugu ^a   Ohigashi, Takashi ^a   Marumo, Ken ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Extraprostatic disease; Pathological stage; Prostate cancer; Tumor diameter; Tumor volume

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MICROVASCULATURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERINEURIUM; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TISSUE SECTION; TUMOR VOLUME;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745898817     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01446.x     Document Type: Article

References (18)

1. Partin AW, Yoo J, Carter HB et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol. 1993; 150: 110-14.
2. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urol. 2003; 169: 517-23.
3. Palisaan RJ, Graefen M, Karakiewicz PI et al. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur. Urol. 2002; 41: 155-61.
4. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J. Urol. 1989; 142: 763-8.
5. Bahnson RR, Dresner SM, Gooding W, Becich MJ. Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 1989; 15: 149-55.
6. Salomao DR, Graham SD, Bostwick DG. Microvascular invasion in prostate cancer correlates with pathologic stage. Arch. Pathol. Lab. Med. 1995; 119: 1050-4.
7. McNeal JE, Yemoto CE. Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. Am. J. Surg. Pathol. 1996; 20: 1351-60.
8. McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986; 1: 60-3.
9. Humphrey PA, Vollmer RT. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod. Pathol. 1997; 10: 326-33.
10. Horiguchi A, Nakashima J, Horiguchi Y et al. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. Prostate 2003; 56: 23-9.
11. Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am. J. Surg. Pathol. 1996; 20: 286-92.
12. Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum. Pathol. 1990; 21: 799-804.
13. Humphrey PA, Frazier HA, Vollmer RT, Paulson DF. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels. Cancer 1993; 71: 1821-7.
14. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am. J. Surg. Pathol. 1990; 14: 240-7.
15. Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J. Urol. 1988; 139: 1235-41.
16. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J. Urol. 1993; 149: 1478-81.
17. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J. Urol. 1989; 141: 341-5.
18. Renshaw AA, Chang H, D'Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am. J. Clin. Pathol. 1997; 107: 704-8.